Fenghao Geng
- Pharmacology top 10%
- Berberine and alkaloids research 6
- Plant-based Medicinal Research 2
- Pharmacology top 10%
- Berberine and alkaloids research 6
- Plant-based Medicinal Research 2
-
- Cancer, Hypoxia, and Metabolism 3
-
- Effects of Radiation Exposure 4
-
- PARP inhibition in cancer therapy 3
-
- interferon and immune responses 2
-
- Inflammasome and immune disorders 2
- Ubiquitin and proteasome pathways 2
- Journals
- SHILAP Revista de lepidopterología (3 papers)Journal of the American College of Cardiology (2 papers)British Journal of Pharmacology (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Fenghao Geng
20 papers receiving 387 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 136
- Pharmacology 60
- Geriatrics and Gerontology 13
- Cancer Research 48
- Complementary and alternative medicine 23
Countries citing papers authored by Fenghao Geng
This map shows the geographic impact of Fenghao Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghao Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghao Geng more than expected).
Fields of papers citing papers by Fenghao Geng
This network shows the impact of papers produced by Fenghao Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghao Geng. The network helps show where Fenghao Geng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fenghao Geng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 6 | |
| 13 | 2019 | 30 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 56 | |
| 16 | 2016 | 60 | |
| 17 | 2014 | 1 | |
| 18 | 2014 | 1 | |
| 19 | 2014 | 150 | |
| 20 | 2013 | 1 |
About Fenghao Geng
Fenghao Geng is a scholar working on Pharmacology, Cancer Research and Pharmacology, having authored 21 papers that have together received 388 indexed citations. Recurring topics across this work include Berberine and alkaloids research (6 papers), Effects of Radiation Exposure (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), PARP inhibition in cancer therapy (3 papers), interferon and immune responses (2 papers), Inflammasome and immune disorders (2 papers), Ubiquitin and proteasome pathways (2 papers) and Plant-based Medicinal Research (2 papers). The work is most often cited by research in Pharmacology (136 citations), Pharmacology (60 citations) and Geriatrics and Gerontology (13 citations). Fenghao Geng has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Ling Dong, Feng Gao, Guohua Li, Min Yang, Keke Chen, Jiani Li, Zhao Zhang, Xing Zhang, Shuyu Zhang and Peng Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.